Janux Therapeutics Inc (JANX)
56.18
-0.56
(-1.00%)
USD |
NASDAQ |
Dec 24, 12:23
Janux Therapeutics Cash from Investing (Quarterly): 12.67M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Rezolute Inc | -49.41M |
| Vir Biotechnology Inc | 118.60M |
| Cytokinetics Inc | -45.05M |
| Galectin Therapeutics Inc | -- |
| Spero Therapeutics Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.231M |
| Cash from Financing (Quarterly) | 1.649M |
| Free Cash Flow | -37.82M |
| Free Cash Flow Per Share (Quarterly) | -0.0413 |
| Free Cash Flow to Equity (Quarterly) | -2.256M |
| Free Cash Flow Yield | -1.31% |